Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

New orally available interferon inducer from Dainippon Sumitomo

Feb. 20, 2006

Methylnaltrexone shows rapid response in treating opioid-induced constipation

Feb. 20, 2006

ANA-380 achieves robust viral load reduction in lamivudine-resistant HBV patients

Feb. 17, 2006

OPT-80 shows efficacy in CDAD in phase IIa studies

Feb. 17, 2006

Novel treatments for gastrointestinal disorders described in recent patents

Feb. 14, 2006

New potent and selective HCV polymerase inhibitors are effective against multiple genotypes

Feb. 13, 2006

Alvimopan reduces time to recover GI function following bowel resection surgery

Feb. 10, 2006

New treatments for hepatitis C described in recent Boehringer Ingelheim patent

Feb. 9, 2006

Telbivudine submitted for European approval

Feb. 8, 2006

Arrow advances lead hepatitis C compound into full preclinical development

Feb. 8, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...